Actively Recruiting
Berlin-Brandenburg Pregnancy Cohort
Led by Charite University, Berlin, Germany · Updated on 2018-08-14
1580
Participants Needed
1
Research Sites
522 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will investigate the interplay of different immune cells and placental cells as well as their potential for the development of pregnancy complications. In particular, the translation of the uteroplacental syndrome into a maternal syndrome, considered in the multifactorial pregnancy disorder preeclampsia, will be investigated. Immune cell subtypes are causally involved in the formation and translation of preeclampsia by inducing an endothelial dysfunction which leads to cardiovascular damage.
CONDITIONS
Official Title
Berlin-Brandenburg Pregnancy Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women who are healthy and have given informed consent
- Pregnant women diagnosed with preeclampsia, gestational hypertension, or gestational diabetes
You will not qualify if you...
- Presence of infections
- Alcohol or drug abuse
- Manifest and chronic diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Experimental and Clinical Research Center (ECRC)
Berlin, Germany, 13125
Actively Recruiting
Research Team
F
Florian Herse, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here